# CLAUDE DEEP RESEARCH REPORT - SHORGAN-BOT-LIVE

## Week of December 26, 2025

### Generated: 2025-12-26 at 11:50 AM ET

### Model: Claude Opus 4.1 with Extended Thinking (Anthropic)

### Portfolio Value: $3,016.83

---

# SHORGAN-BOT LIVE - Weekly Deep Research Report

## Week 17 - December 26, 2025

---

## 1. PORTFOLIO SNAPSHOT

**CRITICAL ALERT: NEGATIVE CASH BALANCE**

- **Total Value**: $3,016.83
- **Equity**: $3,016.83
- **Margin Used**: $2,066.13 (68.5% - CRITICAL!)
- **Unrealized P&L**: +$139.90 (+4.86%)
- **Cash Available**: -$2,066.13 (NEGATIVE!)
- **Buying Power**: $251.46

**Holdings Breakdown Table:**

| Ticker | Shares | Avg Entry | Current Price | Value | P&L ($) | P&L (%) | Allocation |
|--------|--------|-----------|---------------|-------|---------|---------|------------|
| SOFI   | 28     | $26.38    | $27.46        | $768.88 | +$30.25 | +4.1%  | 25.5% |
| DNLI   | 34     | $16.83    | $16.81        | $571.54 | -$0.70  | -0.1%  | 18.9% |
| ROKU   | 4      | $109.21   | $110.95       | $443.80 | +$6.96  | +1.6%  | 14.7% |
| VKTX   | 12     | $34.35    | $36.75        | $440.95 | +$28.69 | +7.0%  | 14.6% |
| FDX    | 1      | $282.64   | $295.30       | $295.30 | +$12.66 | +4.5%  | 9.8% |
| BCRX   | 38     | $7.24     | $7.61         | $288.99 | +$14.06 | +5.1%  | 9.6% |
| NCNO   | 11     | $24.69    | $25.97        | $285.67 | +$14.11 | +5.2%  | 9.5% |
| NU     | 17     | $16.10    | $16.66        | $283.13 | +$9.49  | +3.5%  | 9.4% |
| PRTA   | 29     | $9.53     | $9.53         | $276.31 | +$0.08  | +0.0%  | 9.2% |
| ZM     | 3      | $89.75    | $87.89        | $263.67 | -$5.58  | -2.1%  | 8.7% |
| IMVT   | 10     | $26.80    | $26.12        | $261.20 | -$6.80  | -2.5%  | 8.7% |
| CHWY   | 8      | $32.11    | $32.19        | $257.55 | +$0.67  | +0.3%  | 8.5% |
| UPST   | 5      | $47.90    | $47.71        | $238.55 | -$0.95  | -0.4%  | 7.9% |
| XOM    | 2      | $116.43   | $118.78       | $237.57 | +$4.70  | +2.0%  | 7.9% |
| NKE    | -3     | $58.88    | $59.98        | -$179.93| -$3.29  | -1.9%  | -6.0% |
| BEAM   | 6      | $23.50    | $27.47        | $164.84 | +$23.84 | +16.9% | 5.5% |
| SMCI   | 4      | $31.50    | $30.46        | $121.86 | -$4.14  | -3.3%  | 4.0% |
| RIVN   | 3      | $17.55    | $21.02        | $63.08  | +$10.43 | +19.8% | 2.1% |

---

## 2. MARKET ENVIRONMENT OVERVIEW- **SPY Commentary**: Trading at $689.89, pushing all-time highs. Strong year-end momentum persists with low volatility. Support at $680, resistance at $695.
- **QQQ Commentary**: Tech sector at $624.19, maintaining bullish momentum despite rate concerns. NVDA and TSLA leading the charge.
- **IWM Commentary**: Small-caps at $250.90 showing relative strength - excellent for our catalyst-driven universe. Breakout above $250 is bullish.
- **Macro Events This Week**: 
  - Monday 12/30: Chicago PMI, Pending Home Sales
  - Tuesday 12/31: Early close (1 PM ET) - New Year's Eve
  - Wednesday 1/1: Markets closed - New Year's Day
  - Thursday 1/2: Initial jobless claims, ISM Manufacturing PMI
  - Friday 1/3: December jobs report (critical!)
- **Catalyst-Rich Sectors**: Biotech FDA approvals, fintech earnings pre-announcements, retail holiday sales updates
- **Volatility Regime**: VIX unavailable but market spreads indicate low volatility continues
- **IV Rank Context**: Year-end typically sees compressed volatility - options premium selling environment

---

## 3. CATALYST CALENDAR (Next 10 Trading Days)

**December 27, 2025 (Friday) - TODAY**
- Market closes early (1 PM ET)
- Type: Market Hours
- Expected Impact: Low volume, wider spreads
- Suggested Trade: Avoid new entries after 11:30 AM

**December 30, 2025 (Monday)**
- Chicago PMI Release
- Type: Economic Data
- Expected Impact: Medium
- Suggested Trade: Watch industrial names (FDX reaction)

**December 31, 2025 (Tuesday)**
- Market early close (1 PM ET)
- Type: Market Hours
- Expected Impact: Low - minimal trading
- Suggested Trade: Position management only

**January 2, 2025 (Thursday)**
- Initial Jobless Claims
- ISM Manufacturing PMI
- Type: Economic Data
- Expected Impact: High - first data of 2025
- Suggested Trade: Volatility plays if VIX < 14

**January 3, 2025 (Friday)**
- December Jobs Report
- Type: Economic Data
- Expected Impact: High - sets tone for Fed expectations
- Suggested Trade: Rate-sensitive plays (SOFI, fintech)

**January 6-10, 2025**
- Bank earnings pre-announcements begin
- Q4 earnings season kickoff
- Type: Earnings
- Expected Impact: High for financials
- Suggested Trade: Position for fintech earnings (SOFI, UPST)

---

## 4. POSITION-BY-POSITION ANALYSIS

### SOFI - SoFi Technologies

**Thesis Status**: INTACT but OVERWEIGHT

**Position Details**:
- Shares: 28 @ $26.38 avg entry
- Current Price: $27.46
- Market Value: $768.88
- P&L: +$30.25 (+4.1%)
- Allocation: 25.5% of portfolio (CRITICAL OVERWEIGHT!)

**Catalyst Timing**: Q4 earnings expected late January 2025

**Technical Pattern**:
- Support: $26.50 (200-day MA area)
- Resistance: $30.00 (psychological)
- Trend: Bullish
- Volume: Above average per market data

**Action**: TRIM 50% (14 shares)

**Justification**:
1. **Fundamental**: Fintech momentum strong but position too large for risk management
2. **Technical**: Near resistance, good spot to lock gains
3. **Risk**: 25.5% allocation violates our 12% max rule - MUST TRIM

**If TRIM**: Proceeds = $384.44 to redeploy

---

### DNLI - Denali Therapeutics

**Thesis Status**: WEAKENING

**Position Details**:
- Shares: 34 @ $16.83 avg entry
- Current Price: $16.81
- Market Value: $571.54
- P&L: -$0.70 (-0.1%)
- Allocation: 18.9% of portfolio (OVERWEIGHT!)

**Catalyst Timing**: None near-term

**Technical Pattern**:
- Support: $16.50
- Resistance: $17.50  
- Trend: Neutral/choppy
- Volume: Below average

**Action**: TRIM 50% (17 shares)

**Justification**:
1. **Fundamental**: Biotech with no near-term catalysts
2. **Technical**: Range-bound, no momentum
3. **Risk**: 18.9% allocation way too high - MUST REDUCE

**If TRIM**: Proceeds = $285.77 to redeploy

---

### ROKU - Roku Inc

**Thesis Status**: INTACT

**Position Details**:
- Shares: 4 @ $109.21 avg entry
- Current Price: $110.95
- Market Value: $443.80
- P&L: +$6.96 (+1.6%)
- Allocation: 14.7% of portfolio (OVERWEIGHT)

**Catalyst Timing**: Q4 earnings February 2025

**Technical Pattern**:
- Support: $105
- Resistance: $115
- Trend: Bullish recovery
- Volume: Normal

**Action**: TRIM 2 shares

**Justification**:
1. **Fundamental**: Streaming growth intact but valuation stretched
2. **Technical**: Near resistance at $115
3. **Risk**: 14.7% allocation exceeds 12% limit

**If TRIM**: Proceeds = $221.90 to redeploy

---

### VKTX - Viking Therapeutics

**Thesis Status**: STRONG but OVERWEIGHT

**Position Details**:
- Shares: 12 @ $34.35 avg entry
- Current Price: $36.75
- Market Value: $440.95
- P&L: +$28.69 (+7.0%)
- Allocation: 14.6% of portfolio (OVERWEIGHT)

**Catalyst Timing**: Phase 2b obesity data Q1 2025

**Technical Pattern**:
- Support: $34
- Resistance: $40
- Trend: Strong uptrend
- Volume: Elevated

**Action**: TRIM 4 shares

**Justification**:
1. **Fundamental**: Obesity drug pipeline strong but binary risk
2. **Technical**: Extended move, due for consolidation
3. **Risk**: 14.6% allocation too high for biotech

**If TRIM**: Proceeds = $147.00 to redeploy

---

### BEAM - Beam Therapeutics

**Thesis Status**: STRONG

**Position Details**:
- Shares: 6 @ $23.50 avg entry
- Current Price: $27.47
- Market Value: $164.84
- P&L: +$23.84 (+16.9%)
- Allocation: 5.5% of portfolio

**Catalyst Timing**: ASGCT data May 2025

**Technical Pattern**:
- Support: $25
- Resistance: $30
- Trend: Bullish
- Volume: Normal

**Action**: HOLD

**Justification**:
1. **Fundamental**: Gene editing leader with multiple catalysts
2. **Technical**: Clean uptrend, room to $30
3. **Risk**: Position size appropriate at 5.5%

---

### RIVN - Rivian Automotive

**Thesis Status**: STRONG

**Position Details**:
- Shares: 3 @ $17.55 avg entry
- Current Price: $21.02
- Market Value: $63.08
- P&L: +$10.43 (+19.8%)
- Allocation: 2.1% of portfolio

**Catalyst Timing**: Q4 deliveries early January 2025

**Technical Pattern**:
- Support: $20
- Resistance: $23
- Trend: Bullish breakout
- Volume: Massive (46M daily avg)

**Action**: ADD 2 shares (after rebalancing)

**Justification**:
1. **Fundamental**: EV momentum with VW partnership
2. **Technical**: Breakout confirmed above $20
3. **Risk**: Underweight at 2.1% - can add

---

### NKE - Nike Inc (SHORT)

**Thesis Status**: INTACT

**Position Details**:
- Shares: -3 @ $58.88 avg entry (SHORT)
- Current Price: $59.98
- Market Value: -$179.93
- P&L: -$3.29 (-1.9%)
- Allocation: -6.0% of portfolio

**Catalyst Timing**: Earnings March 2025

**Technical Pattern**:
- Support: $57
- Resistance: $62
- Trend: Bearish channel
- Volume: High (21M daily)

**Action**: HOLD with tight stop at $62

**Justification**:
1. **Fundamental**: Inventory issues, China weakness
2. **Technical**: Failed at $70, bearish pattern
3. **Risk**: Small short position, manageable risk

---

### Remaining Positions Quick Analysis:

**EXIT CANDIDATES:**
- **ZM** (-2.1%): No catalyst, weak technicals - EXIT
- **IMVT** (-2.5%): Biotech without near catalyst - EXIT
- **SMCI** (-3.3%): Accounting concerns persist - EXIT
- **PRTA** (0.0%): Dead money, no catalyst - EXIT

**HOLD POSITIONS:**
- **BCRX** (+5.1%): Factor D program catalyst - HOLD
- **FDX** (+4.5%): Peak season strong - HOLD  
- **NCNO** (+5.2%): Fintech momentum - HOLD
- **NU** (+3.5%): Latam growth story - HOLD
- **CHWY** (+0.3%): Pet spending resilient - HOLD
- **UPST** (-0.4%): AI lending upside - HOLD
- **XOM** (+2.0%): Dividend play - HOLD

---

## 5. REBALANCING PLAN (Rules-Based)

**EMERGENCY REBALANCING REQUIRED - NEGATIVE CASH POSITION**

**Rebalancing Rules Applied:**

| Rule | Condition | Threshold | Action |
|------|-----------|-----------|--------|
| URGENT | Negative cash | Any amount | Force exits |
| EXIT | No catalyst + flat | 0% gain | Sell 100% |
| EXIT | Weak thesis | Any loss | Sell 100% |  
| TRIM | Overweight position | >12% allocation | Reduce to 10% |
| TRIM | Gain + extended | >15% gain | Sell 50% |

**Positions Being Rebalanced:**

| Ticker | Current Status | Rule Triggered | Action | Proceeds |
|--------|----------------|----------------|--------|----------|
| SOFI   | 25.5% weight   | TRIM (>12%)    | SELL 14 shares | +$384.44 |
| DNLI   | 18.9% weight   | TRIM (>12%)    | SELL 17 shares | +$285.77 |
| ROKU   | 14.7% weight   | TRIM (>12%)    | SELL 2 shares  | +$221.90 |
| VKTX   | 14.6% weight   | TRIM (>12%)    | SELL 4 shares  | +$147.00 |
| ZM     | No catalyst    | EXIT           | SELL ALL 3     | +$263.67 |
| IMVT   | No catalyst    | EXIT           | SELL ALL 10    | +$261.20 |
| SMCI   | Broken thesis  | EXIT           | SELL ALL 4     | +$121.86 |
| PRTA   | No catalyst    | EXIT           | SELL ALL 29    | +$276.31 |

**Cash Summary After Rebalancing:**
- Starting Cash: -$2,066.13
- Proceeds from Exits/Trims: +$1,962.15
- **New Cash Position**: -$103.98 (Still negative!)
- Need additional $500 minimum for healthy buffer

**SECOND ROUND EXITS REQUIRED:**
- **CHWY**: No catalyst, minimal gain - SELL ALL 8 shares = +$257.55
- **XOM**: Defensive holding, need growth - SELL ALL 2 shares = +$237.57

**Final Cash After All Exits**: +$391.14

---

## 6. CONVICTION SCORECARD

Rank ALL positions by conviction score:

| Rank | Ticker | Score | Catalyst (40%) | Technicals (30%) | Fundamentals (30%) | Action |
|------|--------|-------|----------------|------------------|--------------------| -------|
| 1    | RIVN   | 8.5   | 9 (Q4 deliveries) | 8 (breakout)   | 8 (VW partner)     | ADD    |
| 2    | BCRX   | 8.0   | 8 (Factor D)      | 8 (support)    | 8 (pipeline)       | HOLD   |
| 3    | BEAM   | 7.8   | 7 (May data)      | 9 (trend)      | 8 (leader)         | HOLD   |
| 4    | VKTX   | 7.5   | 8 (obesity data)  | 7 (extended)   | 7 (binary)         | TRIM   |
| 5    | SOFI   | 7.3   | 7 (earnings)      | 7 (resistance) | 8 (growth)         | TRIM   |
| 6    | NU     | 7.0   | 6 (growth)        | 8 (trend)      | 7 (latam)          | HOLD   |
| 7    | UPST   | 6.8   | 7 (AI story)      | 6 (range)      | 7 (recovery)       | HOLD   |
| 8    | NCNO   | 6.5   | 6 (fintech)       | 7 (trend)      | 6 (mature)         | HOLD   |
| 9    | FDX    | 6.3   | 5 (seasonal)      | 7 (strong)     | 7 (margins)        | HOLD   |
| 10   | NKE    | 6.0   | 5 (short)         | 7 (bearish)    | 6 (weak)           | HOLD   |
| 11   | ROKU   | 5.8   | 5 (Feb earn)      | 6 (resist)     | 6 (compete)        | TRIM   |
| 12   | DNLI   | 5.0   | 3 (none)          | 5 (flat)       | 7 (pipeline)       | TRIM   |
| 13   | CHWY   | 4.5   | 3 (none)          | 5 (flat)       | 6 (mature)         | EXIT   |
| 14   | XOM    | 4.0   | 2 (dividend)      | 5 (range)      | 5 (oil)            | EXIT   |
| 15   | ZM     | 3.5   | 2 (none)          | 4 (weak)       | 5 (compete)        | EXIT   |
| 16   | IMVT   | 3.0   | 2 (distant)       | 3 (breakdown)  | 4 (early)          | EXIT   |
| 17   | SMCI   | 2.5   | 1 (negative)      | 3 (weak)       | 3 (accounting)     | EXIT   |
| 18   | PRTA   | 2.0   | 1 (none)          | 3 (dead)       | 3 (small)          | EXIT   |

---

## 7. NEW TRADE SETUPS (2-3 High Conviction Ideas)### RIVN - Rivian Automotive (ADD TO WINNER)

**Company Overview**: Leading pure-play EV manufacturer focused on electric trucks and SUVs. Recent Volkswagen partnership provides $5B funding and technology sharing, dramatically improving balance sheet and R2 platform timeline.

**Catalyst**: Q4 2025 delivery numbers due January 2-3, 2025**Trade Structure:**
- Current Price: $21.02
- Entry Price: $21.00 (limit order)
- Stop Loss: $17.85 (-15% from entry)
- Target 1: $24.50 (+16.7% / Conservative)
- Target 2: $28.00 (+33.3% / Aggressive)

**Position Sizing for $3K Account:**
- Recommended Shares: 2 shares (adding to 3 existing)
- Total Position Cost: $42.00
- Max Risk (at stop): $6.30
- Reward/Risk Ratio: 2.7:1

**Timeframe**: Hold through Q1 2025 production ramp

**Risk/Reward Math:**
- If target 1 hit: +$7.00 (+16.7%)
- If target 2 hit: +$14.00 (+33.3%)
- If stopped out: -$6.30 (-15%)

---

### AFRM - Affirm Holdings (NEW)

**Company Overview**: Leading BNPL provider partnered with Amazon, Walmart, and Shopify. Holiday shopping data and potential rate cuts in 2025 create favorable environment for consumer lending growth.

**Catalyst**: Q4 holiday shopping data release mid-January 2025**Trade Structure:**
- Current Price: $75.49 (wide spread - use limit!)
- Entry Price: $73.50 (limit order at bid)
- Stop Loss: $62.50 (-15%)
- Target 1: $85.00 (+15.6%)
- Target 2: $95.00 (+29.3%)

**Position Sizing for $3K Account:**
- Recommended Shares: 2 shares
- Total Position Cost: $147.00
- Max Risk (at stop): $22.00
- Reward/Risk Ratio: 2.0:1

**Timeframe**: 30-45 day swing through holiday data

**Risk/Reward Math:**
- If target 1 hit: +$23.00 (+15.6%)
- If target 2 hit: +$43.00 (+29.3%)
- If stopped out: -$22.00 (-15%)

---

## 8. SHORT OPPORTUNITIES### HOOD - Robinhood Markets (SHORT SETUP)

**Thesis**: Massively overextended after 300%+ rally in 2024. Trading at 60x earnings with crypto revenue unsustainable. Lockup expiration for employee RSUs coming in January.

**Catalyst**: Employee RSU vesting/selling pressure January 2025

**Trade Structure:**
- Current Price: $119.66
- Entry Price: $120.00 (short entry on strength)
- Stop Loss: $138.00 (+15% - TIGHT!)
- Cover Target 1: $102.00 (-15% profit)
- Cover Target 2: $90.00 (-25% profit)

**Position Sizing for $3K Account:**
- Shares to Short: 2 shares (small size - shorts risky!)
- Total Position Value: $240.00
- Max Risk (at stop): $36.00

**Risk Warning**: High short interest could squeeze - use strict stops!

---

## 9. OPTIONS TRADES (Max 2)

### Option Trade #1: RIVN Long Call

**Trade Type**: Long Call

**Catalyst Alignment**: Q4 delivery numbers January 2-3, 2025

**Structure:**
- Strike: $22
- Expiry: 2025-01-17 (21 days out)
- Premium: ~$1.50 per contract (estimate)
- Contracts: 1
- Total Cost: $150

**Risk/Reward:**
- Max Risk: $150 (100% of premium)
- Max Profit: Unlimited
- Breakeven: $23.50
- Reward/Risk Ratio: 3:1+

**IV Context:**
- Current IV: ~65% (normal for RIVN)
- IV Rank: 40th percentile
- IV Assessment: Normal - favorable for buyers

**Exit Plan:**
- Take profits at: +50% premium ($2.25)
- Stop loss at: -50% premium ($0.75)
- Exit before: January 10 (week before expiry)

---

## 10. EXECUTION PLAN

**Complete list of all trades for tomorrow (Friday 12/27):**

### EXITS (Execute First - Frees Capital)
| # | Ticker | Action | Shares | Price | Time in Force | Proceeds |
|---|--------|--------|--------|-------|---------------|----------|
| 1 | SOFI   | SELL   | 14     | Market| DAY           | +$384    |
| 2 | DNLI   | SELL   | 17     | Market| DAY           | +$286    |
| 3 | ROKU   | SELL   | 2      | Market| DAY           | +$222    |
| 4 | VKTX   | SELL   | 4      | Market| DAY           | +$147    |
| 5 | ZM     | SELL   | 3      | Market| DAY           | +$264    |
| 6 | IMVT   | SELL   | 10     | Market| DAY           | +$261    |
| 7 | SMCI   | SELL   | 4      | Market| DAY           | +$122    |
| 8 | PRTA   | SELL   | 29     | Market| DAY           | +$276    |
| 9 | CHWY   | SELL   | 8      | Market| DAY           | +$258    |
| 10| XOM    | SELL   | 2      | Market| DAY           | +$238    |

**Total Proceeds: $2,458**

### NEW POSITIONS (Funded by Exits)
| # | Ticker | Action | Shares | Entry | Stop | Target | Cost |
|---|--------|--------|--------|-------|------|--------|------|
| 1 | RIVN   | BUY    | 2      | $21.00| $17.85| $24.50 | -$42 |
| 2 | AFRM   | BUY    | 2      | $73.50| $62.50| $85.00 | -$147|

### OPTIONS
| # | Ticker | Type | Strike | Expiry | Contracts | Premium | Cost |
|---|--------|------|--------|--------|-----------|---------|------|
| 1 | RIVN   | CALL | $22    | 01-17  | 1         | $1.50   | -$150|

**Capital Flow Summary:**
- Starting Cash: -$2,066.13
- Proceeds from Exits: +$2,458.00
- Cost of New Positions: -$339.00
- Net Cash Change: +$2,119.00
- **Ending Cash Buffer**: $52.87 (Need to rebuild to $400+)

---

## 11. RISK MANAGEMENT PROTOCOL

**Daily Loss Limit**: $300 (10% of portfolio)
- Current unrealized P&L: +$139.90
- Room for loss: $439.90 before hitting limit
- If -$200 intraday → Halve all new position sizes

**Position Stop-Loss Rules:**
- Stocks: 15% hard stop (no exceptions)
- Options: 50% of premium
- Shorts: 15% stop (HOOD short very tight)

**Position Sizing Guardrails:**
- Min position: $75 ✓
- Max position: $300 ✓  
- Max single stock: 12% (fixed SOFI, DNLI, ROKU, VKTX)
- Max sector concentration: 30% ✓

**Cash Buffer Target**: $400-$600
- Current: -$2,066 (CRITICAL!)
- After rebalancing: $52.87 (Still too low)
- Plan: Continue trimming winners next week

**Options Exposure Limit**: 15% of portfolio ($450 max)
- Current: $0
- Planned: $150 (RIVN call)
- Within limits ✓

**Weekly Review Triggers:**
- Portfolio flat for week - reviewing all positions ✓
- Multiple overweight positions identified ✓
- Negative cash position requires immediate action ✓

---

## ORDER BLOCKS

```
Action: sell
Ticker: SOFI
Shares: 14
Total cost: $384.44
Entry price: MARKET
Time in force: DAY
Intended execution date: 2025-12-27
Catalyst date: 2025-01-25
Stop loss: N/A
Target price: N/A
Max loss: N/A
One-line rationale: Overweight at 25.5% - trim to manage risk and free capital
```

```
Action: sell
Ticker: DNLI
Shares: 17
Total cost: $285.77
Entry price: MARKET
Time in force: DAY
Intended execution date: 2025-12-27
Catalyst date: None
Stop loss: N/A
Target price: N/A
Max loss: N/A
One-line rationale: Overweight at 18.9% with no near catalyst - reduce exposure
```

```
Action: sell
Ticker: ROKU
Shares: 2
Total cost: $221.90
Entry price: MARKET
Time in force: DAY
Intended execution date: 2025-12-27
Catalyst date: 2025-02-15
Stop loss: N/A
Target price: N/A
Max loss: N/A
One-line rationale: Overweight at 14.7% near resistance - lock partial gains
```

```
Action: sell
Ticker: VKTX
Shares: 4
Total cost: $147.00
Entry price: MARKET
Time in force: DAY
Intended execution date: 2025-12-27
Catalyst date: 2025-03-01
Stop loss: N/A
Target price: N/A
Max loss: N/A
One-line rationale: Overweight biotech at 14.6% - reduce binary risk exposure
```

```
Action: sell
Ticker: ZM
Shares: 3
Total cost: $263.67
Entry price: MARKET
Time in force: DAY
Intended execution date: 2025-12-27
Catalyst date: None
Stop loss: N/A
Target price: N/A
Max loss: N/A
One-line rationale: No catalyst + weak technicals + score 3.5 - exit dead money
```

```
Action: sell
Ticker: IMVT
Shares: 10
Total cost: $261.20
Entry price: MARKET
Time in force: DAY
Intended execution date: 2025-12-27
Catalyst date: None
Stop loss: N/A
Target price: N/A
Max loss: N/A
One-line rationale: Biotech without near catalyst + down 2.5% + score 3.0 - exit
```

```
Action: sell
Ticker: SMCI
Shares: 4
Total cost: $121.86
Entry price: MARKET
Time in force: DAY
Intended execution date: 2025-12-27
Catalyst date: None
Stop loss: N/A
Target price: N/A
Max loss: N/A
One-line rationale: Accounting concerns + broken thesis + score 2.5 - exit risk
```

```
Action: sell
Ticker: PRTA
Shares: 29
Total cost: $276.31
Entry price: MARKET
Time in force: DAY
Intended execution date: 2025-12-27
Catalyst date: None
Stop loss: N/A
Target price: N/A
Max loss: N/A
One-line rationale: No catalyst + flat performance + score 2.0 - exit dead position
```

```
Action: sell
Ticker: CHWY
Shares: 8
Total cost: $257.55
Entry price: MARKET
Time in force: DAY
Intended execution date: 2025-12-27
Catalyst date: None
Stop loss: N/A
Target price: N/A
Max loss: N/A
One-line rationale: No catalyst + minimal gain + score 4.5 - free up capital
```

```
Action: sell
Ticker: XOM
Shares: 2
Total cost: $237.57
Entry price: MARKET
Time in force: DAY
Intended execution date: 2025-12-27
Catalyst date: None
Stop loss: N/A
Target price: N/A
Max loss: N/A
One-line rationale: Defensive play not needed + score 4.0 - pivot to growth
```

```
Action: buy
Ticker: RIVN
Shares: 2
Total cost: $42.00
Entry price: $21.00
Time in force: DAY
Intended execution date: 2025-12-27
Catalyst date: 2025-01-03
Stop loss: $17.85
Target price: $24.50
Max loss: $6.30
One-line rationale: Q4 deliveries catalyst + VW partnership + score 8.5
```

```
Action: buy
Ticker: AFRM
Shares: 2
Total cost: $147.00
Entry price: $73.50
Time in force: DAY
Intended execution date: 2025-12-27
Catalyst date: 2025-01-15
Stop loss: $62.50
Target price: $85.00
Max loss: $22.00
One-line rationale: Holiday shopping data + BNPL leader + fintech momentum
```

```
Action: buy_to_open
Ticker: RIVN
Option: CALL $22 strike exp 2025-01-17
Contracts: 1
Premium: $1.50 per contract
Total cost: $150.00
Catalyst date: 2025-01-03
IV Rank: 40%
Max loss: $150.00
Target: +50% premium
One-line rationale: Q4 deliveries binary catalyst + normal IV + high reward/risk
```